These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8617331

  • 41. The combined epidermal growth factor-like modules of Plasmodium yoelii Merozoite Surface Protein-1 are required for a protective immune response to the parasite.
    Ling IT, Ogun SA, Holder AA.
    Parasite Immunol; 1995 Aug; 17(8):425-33. PubMed ID: 7501423
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria.
    Keitany GJ, Sack B, Smithers H, Chen L, Jang IK, Sebastian L, Gupta M, Sather DN, Vignali M, Vaughan AM, Kappe SH, Wang R.
    Infect Immun; 2014 Dec; 82(12):5143-53. PubMed ID: 25267837
    [Abstract] [Full Text] [Related]

  • 47. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites.
    Ak M, Bower JH, Hoffman SL, Sedegah M, Lees A, Carter M, Beaudoin RL, Charoenvit Y.
    Infect Immun; 1993 Jun; 61(6):2493-7. PubMed ID: 8500885
    [Abstract] [Full Text] [Related]

  • 48. Passive immunization against murine malaria with an IgG3 monoclonal antibody.
    Majarian WR, Daly TM, Weidanz WP, Long CA.
    J Immunol; 1984 Jun; 132(6):3131-7. PubMed ID: 6725950
    [Abstract] [Full Text] [Related]

  • 49. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.
    Kaslow DC, Quakyi IA, Syin C, Raum MG, Keister DB, Coligan JE, McCutchan TF, Miller LH.
    Nature; 1988 May 05; 333(6168):74-6. PubMed ID: 3283563
    [Abstract] [Full Text] [Related]

  • 50. Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection.
    Alaro JR, Lynch MM, Burns JM.
    Vaccine; 2010 Oct 04; 28(42):6876-84. PubMed ID: 20709001
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Immunization with recombinant Plasmodium yoelii merozoite surface protein 4/5 protects mice against lethal challenge.
    Kedzierski L, Black CG, Coppel RL.
    Infect Immun; 2000 Oct 04; 68(10):6034-7. PubMed ID: 10992516
    [Abstract] [Full Text] [Related]

  • 53. Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.
    Narum DL, Ogun SA, Thomas AW, Holder AA.
    Infect Immun; 2000 May 04; 68(5):2899-906. PubMed ID: 10768987
    [Abstract] [Full Text] [Related]

  • 54. Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii.
    Kedzierski L, Black CG, Goschnick MW, Stowers AW, Coppel RL.
    Infect Immun; 2002 Dec 04; 70(12):6606-13. PubMed ID: 12438332
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Immunity to erythrocytic stages of malarial parasites.
    Long CA, Daly TM, Kima P, Srivastava I.
    Am J Trop Med Hyg; 1994 Dec 04; 50(4 Suppl):27-32. PubMed ID: 7909653
    [Abstract] [Full Text] [Related]

  • 58. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.
    Kawabata Y, Udono H, Honma K, Ueda M, Mukae H, Kadota J, Kohno S, Yui K.
    Infect Immun; 2002 Nov 04; 70(11):6075-82. PubMed ID: 12379684
    [Abstract] [Full Text] [Related]

  • 59. Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen.
    Freeman RR, Holder AA.
    Clin Exp Immunol; 1983 Dec 04; 54(3):609-16. PubMed ID: 6652973
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.